Avient vs Fuller H B
AVNT and FUL side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AVNT and FUL compare
Avient is the larger company, worth 1.5 times as much as Fuller H B ($4.1B against $2.7B).
On earnings, Fuller H B is cheaper: it trades at 13.7× trailing earnings, against 22.9× for Avient.
Avient grew revenue faster over the last twelve months (5.2% versus 1.5% for Fuller H B).
Fuller H B keeps more of each dollar of sales as profit, with a net margin of 5.6% compared with 5.3% at Avient.
Both pay dividends: Avient yields 2.5% and Fuller H B 2.0%.
Fuller H B scores higher on the StockData Score (18 against 13 for Avient), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AVNT | FUL |
|---|---|---|
| Size and price | ||
| Market cap | $4.1B | $2.7B |
| Share price | $44.66 | $49.29 |
| Change, 1 year | 51.6% | −14.8% |
| Change, 5 years | −25.6% | −35.6% |
| Beta (5Y) | 1.33 | 0.95 |
| Employees | 9,000 | 7,100 |
| StockData Score | ||
| Total score | 13 | 18 (better) |
| Valuation score | 3 | 6 (better) |
| Growth score | 2 | 3 (better) |
| Performance score | 2 | 3 (better) |
| Health score | 2 | 2 |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 22.9× | 13.7× (better) |
| P/S | 1.2× | 0.7× (better) |
| P/B | 1.7× | 1.2× (better) |
| EV/EBITDA | 10.5× | 7.9× (better) |
| P/FCF | 17.1× (better) | 26.5× |
| FCF yield | 5.8% (better) | 3.8% |
| Fair value | $54.00 | $102.06 |
| Margin of safety | 17.3% | 51.7% (better) |
| Growth | ||
| Revenue growth (TTM) | 5.2% (better) | 1.5% |
| Revenue growth, 5Y average | 8.0% (better) | 4.5% |
| Net income growth (TTM) | 59.0% | 72.2% (better) |
| EPS growth (TTM) | 57.3% | 71.8% (better) |
| EPS growth, 5Y average | −9.3% | 3.1% (better) |
| Profitability | ||
| Gross margin | 31.7% | 32.3% (better) |
| Operating margin | 9.7% | – |
| Net margin | 5.3% | 5.6% (better) |
| FCF margin | 7.0% (better) | 2.8% |
| Return on equity | 7.5% | 9.6% (better) |
| Return on invested capital | 6.4% | – |
| Financial health | ||
| Debt / equity | 0.74 (better) | 0.95 |
| Net debt / EBITDA | 2.65 (better) | 3.35 |
| Current ratio | 1.71 | 1.82 (better) |
| Altman Z-score | 1.59 | 1.85 (better) |
| Piotroski F-score | 6 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.5% (better) | 2.0% |
| Payout ratio | 55.7% | 26.2% |
| Years of dividend growth | 15 | 16 (better) |
| Dividend growth, 5Y average | 5.8% | 7.4% (better) |
| Buyback yield | – | 1.8% |
| Shareholder yield | 2.5% | 3.8% (better) |
| Ownership | ||
| Held by institutions | 105% | 104% |
| Held by insiders | 0.83% | 0.65% |
| Insider net buying, 12 months | – | $853K |
| Short interest, % of float | 4.7% | 4.1% |
Go deeper
- AVNT stock overview
- AVNT income statement
- AVNT valuation and score
- FUL stock overview
- FUL income statement
- FUL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.